Hostname: page-component-8448b6f56d-jr42d Total loading time: 0 Render date: 2024-04-19T10:53:39.845Z Has data issue: false hasContentIssue false
  • English
  • Français

Concomitant Viral and Bacterial Encephalitis after Temozolomide for Glioblastoma

Published online by Cambridge University Press:  23 September 2014

Jenny P. Tsai ,
Nicolae Petrescu ,
Warren P. Mason  and
Leanne K. Casaubon
Jenny P. Tsai*
Affiliation:
Division of Neurology, Department of Medicine, University Health Network-Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
Nicolae Petrescu
Affiliation:
Division of Neurology, Department of Medicine, University Health Network-Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
Warren P. Mason
Affiliation:
Division of Neurology, Department of Medicine, University Health Network-Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
Leanne K. Casaubon
Affiliation:
Division of Neurology, Department of Medicine, University Health Network-Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
*
Toronto Western Hospital, University Health Network, West wing, 5th Floor, 399 Bathurst St., Toronto, Ontario, M5T 2S8, Canada. Email: jennyp.tsai@utoronto.ca.
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Neuroimaging Highlight
Information
Canadian Journal of Neurological Sciences , Volume 41 , Issue 1 , January 2014 , pp. 84 - 85
Copyright
Copyright © The Canadian Journal of Neurological 2014

References

1. DeBiasi, RL, Kleinschmidt-DeMasters, BK, Weinberg, A, Tyler, KL. Use of PCR for the diagnosis of herpesvirus infections of the central nervous system. J Clin Virol. 2002 Jul;25 Suppl 1:S5–11.Google Scholar
2. Su, YB. Selective CD4+ Lymphopenia in melanoma patients treated with temozolomide: a toxicity with therapeutic implications. J Clin Oncol. 2004 Feb 15;22(4):610–16.Google ScholarPubMed
3. Gaviani, P, Silvani, A, Lamperti, E, et al. Infections in neurooncology. Neurol Sci. 2011 Oct 15;32(S2):233–6.Google Scholar
4. Schwarzberg, AB, Stover, EH, Sengupta, T, et al. Selective lymphopenia and opportunistic infections in neuroendocrine tumor patients receiving temozolomide. Cancer Invest. 2007 Jan;25(4):249–55.Google Scholar
5. Aregawi, D, Lopez, D, Wick, M, Scheld, WM, Schiff, D. Disseminated strongyloidiasis complicating glioblastoma therapy: a case report. J Neurooncol. 2009 Mar 31;94(3):439–43.Google Scholar
6. Meije, Y, Lizasoain, M, Garcîa Reyne, A, et al. Emergence of cytomegalovirus disease in patients receiving temozolomide: report of two cases and literature review. Clin Infect Dis. 2010 Jun 15;50(12):e73–6.Google Scholar
7. Okita, Y, Narita, Y, Miyakita, Y, Ohno, M, Nagai, S, Shibui, S. Management of Cytomegalovirus infection in a patient with malignant glioma treated with temozolomide and steroids. Intern Med. 2012;51(20):2967–71.Google Scholar
8. Stupp, R, Mason, WP, van den Bent, MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005 Mar 10;352(10):987–96.Google Scholar
9. Sundén, B, Larsson, M, Falkeborn, T, et al. Real-time PCR detection of human herpesvirus 1–5 in patients lacking clinical signs of a viral CNS infection. BMC Infectious Diseases. 2011 Aug 17;11 (1):220.Google Scholar